# The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Injectable SPN01 in Phase I.

> **NCT06710561** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Beijing SonoPhotoNano Medical Technology Co., Ltd.** · enrollment: 32 (estimated)

## Conditions studied

- Colorectal Carcinoma

## Interventions

- **DRUG:** SPN01 for Injection
- **OTHER:** Placebo
- **DRUG:** SPN01 for Injection

## Key facts

- **NCT ID:** NCT06710561
- **Lead sponsor:** Beijing SonoPhotoNano Medical Technology Co., Ltd.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-17
- **Primary completion:** 2026-04-10
- **Final completion:** 2026-04-10
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2024-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06710561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06710561, "The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Injectable SPN01 in Phase I.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06710561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*